- Home
- CRDF vs ATLO Comparison
CRDF vs ATLO Comparison
Compare CRDF & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- ATLO
- Stock Information
- Founded
- CRDF 1999
- ATLO 1903
- Country
- CRDF United States
- ATLO United States
- Employees
- CRDF N/A
- ATLO N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- ATLO Major Banks
- Sector
- CRDF Health Care
- ATLO Finance
- Exchange
- CRDF Nasdaq
- ATLO Nasdaq
- Market Cap
- CRDF 169.6M
- ATLO 158.4M
- IPO Year
- CRDF N/A
- ATLO N/A
- Fundamental
- Price
- CRDF $3.21
- ATLO $17.40
- Analyst Decision
- CRDF Strong Buy
- ATLO
- Analyst Count
- CRDF 5
- ATLO 0
- Target Price
- CRDF $10.50
- ATLO N/A
- AVG Volume (30 Days)
- CRDF 1.2M
- ATLO 12.5K
- Earning Date
- CRDF 08-07-2025
- ATLO 08-08-2025
- Dividend Yield
- CRDF N/A
- ATLO 4.51%
- EPS Growth
- CRDF N/A
- ATLO 14.69
- EPS
- CRDF N/A
- ATLO 1.27
- Revenue
- CRDF $587,000.00
- ATLO $55,041,000.00
- Revenue This Year
- CRDF N/A
- ATLO N/A
- Revenue Next Year
- CRDF N/A
- ATLO N/A
- P/E Ratio
- CRDF N/A
- ATLO $14.00
- Revenue Growth
- CRDF N/A
- ATLO 6.77
- 52 Week Low
- CRDF $2.01
- ATLO $15.69
- 52 Week High
- CRDF $5.64
- ATLO $22.03
- Technical
- Relative Strength Index (RSI)
- CRDF 44.28
- ATLO 52.29
- Support Level
- CRDF $2.96
- ATLO $16.94
- Resistance Level
- CRDF $3.24
- ATLO $17.72
- Average True Range (ATR)
- CRDF 0.28
- ATLO 0.39
- MACD
- CRDF -0.10
- ATLO -0.01
- Stochastic Oscillator
- CRDF 13.03
- ATLO 69.81
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.